Method of regulating cellular processes mediated by B7 and CD28
    6.
    发明授权
    Method of regulating cellular processes mediated by B7 and CD28 失效
    调节由B7和CD28介导的细胞过程的方法

    公开(公告)号:US06641809B1

    公开(公告)日:2003-11-04

    申请号:US08219200

    申请日:1994-03-29

    IPC分类号: A61K3817

    摘要: The invention identifies the B7 antigen as a ligand that is reactive with the CD28 receptor on T cells. Fragments and derivatives of the B7 antigen and CD28 receptor, including fusion proteins having amino acid sequences corresponding to the extracellular domains of B7 or CD28 joined to amino acid sequences encoding portions of human immunoglobulin C&ggr;1, are described. Methods are provided for using B7 antigen, its fragments and derivatives, and the CD28 receptor, its fragments and derivatives, as well as antibodies and other molecules reactive with B7 antigen and/or the CD28 receptor, to regulate CD28 positive T cell responses, and immune responses mediated by T cells. The invention also includes an assay method for detecting ligands reactive with cellular receptors mediating intercellular adhesion.

    摘要翻译: 本发明将B7抗原鉴定为与T细胞上的CD28受体反应的配体。 描述了B7抗原和CD28受体的片段和衍生物,包括与编码部分人免疫球蛋白Cgamma1的氨基酸序列连接的与B7或CD28的细胞外结构域相对应的氨基酸序列的融合蛋白。 提供了使用B7抗原,其片段和衍生物以及CD28受体,其片段和衍生物以及与B7抗原和/或CD28受体反应的抗体和其它分子调节CD28阳性T细胞应答的方法,以及 由T细胞介导的免疫应答。 本发明还包括检测与介导细胞间粘附的细胞受体反应的配体的测定方法。

    CTLA4 Ig fusion proteins
    8.
    发明授权
    CTLA4 Ig fusion proteins 失效
    CTLA4 Ig融合蛋白

    公开(公告)号:US5844095A

    公开(公告)日:1998-12-01

    申请号:US375390

    申请日:1995-01-18

    摘要: The invention identifies the CTLA4 receptor as a ligand for the B7 antigen. The complete amino acid sequence encoding human CTLA4 receptor gene is provided. Methods are provided for expressing CTLA4 as an immunoglobulin fusion protein, for preparing hybrid CTLA4 fusion proteins, and for using the soluble fusion proteins, fragments and derivatives thereof, including monoclonal antibodies reactive with B7 and CTLA4, to regulate T cell interactions and immune responses mediated by such interactions.

    摘要翻译: 本发明鉴定CTLA4受体作为B7抗原的配体。 提供编码人CTLA4受体基因的完整氨基酸序列。 提供用于表达CTLA4作为免疫球蛋白融合蛋白的方法,用于制备杂合CTLA4融合蛋白,并使用可溶性融合蛋白,其片段和衍生物,包括与B7和CTLA4反应的单克隆抗体调节T细胞相互作用和免疫应答介导 通过这种互动。